Understanding and Combating Tuberculosis: A Comprehensive Guide

pharmanewsdaily- July 7, 2024

Tuberculosis (TB) remains one of the most persistent and deadly infectious diseases globally. Caused by various strains of the Mycobacterium tuberculosis bacteria, TB primarily targets ... Read More

Lupin partners with procurement agencies for TB prevention treatment

Pallavi Madhiraju- October 7, 2022

Lupin Limited has entered into partnerships with Unitaid, the Clinton Health Access Initiative (CHAI), The Aurum Institute, and other global procurement agencies for supporting tuberculosis ... Read More

Lupin, TB Alliance partner for new therapy for highly drug-resistant TB

pallavi123- September 6, 2021

Indian pharma company Lupin Limited has secured a non-exclusive license from TB Alliance, a non-profit drug developer, for manufacturing the anti-TB drug pretomanid. Pretomanid is ... Read More

PerkinElmer to acquire TB test kit maker Oxford Immunotec for $591m

pharmanewsdaily- January 16, 2021

US medical diagnostic firm PerkinElmer has agreed to acquire Oxford Immunotec Global, a UK-based diagnostics company, for $22 per share or around $591 million. Oxford ... Read More

LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection

pharmanewsdaily- January 1, 2020

Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus (QFT-Plus automated screening solution) on the latter’s ... Read More